biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > My Opinion of poof's Opinion of Chiesi's CHMP Opinion

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Feb 24, 2023 9:35am

52 Views

Post# 35303020

RE:RE:RE:My Opinion of poof's Opinion of Chiesi's CHMP Opinion

It doesn't matter, boom, whether he is being paid or not. Clearly he has ulterior motives that he refuses to disclose. But who cares? There is pretty much no one here that is even reading his posts. Most everyone already sold so what is he trying to accomplish? There is nothing he can say that will change anything. No one cares. Everyone is gone. He's pretty much talking to a few of us who own no shares.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season